KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Of all the cephalosporins, only first-generation drugs should be considered for the treatment of GAS pharyngitis. The clearest advantage of cephalosporins is for patients in whom eradication of ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with ...

Cephalosporin Drugs Market Snapshot 2024-2032: The <a href=https://www.reportsinsights.com/sample/48690#utm_source=LKD&utm_id=LKD>Cephalosporin Drugs Market 2024 ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of ...

And how much does it really cost to bring a drug to market? Increasingly, though, these debates are happening when everyone knows that the list price is not the ‘real’ price to be paid ...